Loading...
OTCM
INIS
Market cap36mUSD
Dec 05, Last price  
0.07USD
1D
11.11%
1Q
-0.14%
Jan 2017
-40.32%
Name

International Isotopes Inc

Chart & Performance

D1W1MN
OTCM:INIS chart
P/E
4,312.42
P/S
2.66
EPS
0.00
Div Yield, %
Shrs. gr., 5y
4.55%
Rev. gr., 5y
9.19%
Revenues
14m
+13.31%
2,985,4344,469,5384,690,5885,602,4436,122,8446,107,2819,462,0127,621,9346,849,1507,536,8607,062,1966,552,1497,420,39010,368,8238,955,2049,364,8969,661,94211,181,98812,267,38513,899,760
Net income
9k
P
-982,953-1,037,312-1,719,055-2,166,967-4,633,298-6,802,014-5,950,438-2,240,810-2,461,845-1,545,077-1,818,225-1,879,112-3,757,284-844,576-1,949,729-2,216,212-2,377,132-310,705-869,0168,574
CFO
639k
+9.65%
-1,217,424-259,941-916,514-1,476,502-2,385,333-4,563,55666,919-2,734,752-1,393,898339,808339,604-324,176-853,19997,159-53,5571,149,625-161,914-1,497,719582,589638,783

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
IPO date
Aug 14, 1997
Employees
32
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT